Feng Yu
Impact in
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
- SARS-CoV-2 detection and testing
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Pharmacogenetics and Drug Metabolism 6
- Microbial Natural Products and Biosynthesis 3
-
- Cardiac electrophysiology and arrhythmias 2
- Co-authors
- Ji Li (4 shared papers)Weihong Ge (1 shared paper)Huaijun Zhu (1 shared paper)Yubing Zhu (3 shared papers)Kaixian Chen (2 shared papers)Dongxiang Liu (2 shared papers)Xu Shen (2 shared papers)Hualiang Jiang (2 shared papers)
- Journals
- International Journal of Molecular Sciences (3 papers)Acta Pharmacologica Sinica (2 papers)Medicine (2 papers)Evidence-based Complementary and Alternative Medicine (1 paper)Frontiers in Pediatrics (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Feng Yu
37 papers receiving 1.6k citations
Feng Yu's Hit Papers
Peers
Comparison fields: 5 of 96
- Infectious Diseases 775
- Pharmacology 152
- Drug Discovery 2
- Pharmaceutical Science 35
- Geriatrics and Gerontology 14
Countries citing papers authored by Feng Yu
This map shows the geographic impact of Feng Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Yu more than expected).
Fields of papers citing papers by Feng Yu
This network shows the impact of papers produced by Feng Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Yu. The network helps show where Feng Yu may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Yu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals Hit paper breakdown → | 2020 | 854 |
| 2 | 2009 | 95 | |
| 3 | 2020 | 93 | |
| 4 | 2019 | 58 | |
| 5 | 2006 | 52 | |
| 6 | 2012 | 46 | |
| 7 | 2019 | 42 | |
| 8 | 2015 | 31 | |
| 9 | 2009 | 29 | |
| 10 | 2014 | 27 | |
| 11 | 2015 | 27 | |
| 12 | 2022 | 26 | |
| 13 | 2009 | 24 | |
| 14 | 2012 | 24 | |
| 15 | 2017 | 21 | |
| 16 | 2016 | 20 | |
| 17 | 2017 | 19 | |
| 18 | 2021 | 18 | |
| 19 | 2021 | 18 | |
| 20 | 2025 | 16 |
About Feng Yu
Feng Yu is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine, Infectious Diseases, Pharmacology and Oncology, having authored 40 papers that have together received 1.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (6 papers), Nephrotoxicity and Medicinal Plants (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Microbial Natural Products and Biosynthesis (3 papers), Drug Solubulity and Delivery Systems (2 papers), Curcumin's Biomedical Applications (2 papers), Mitochondrial Function and Pathology (2 papers) and Cardiac electrophysiology and arrhythmias (2 papers). The work is most often cited by research in Infectious Diseases (775 citations), Pharmacology (152 citations), Drug Discovery (2 citations), Pharmaceutical Science (35 citations) and Geriatrics and Gerontology (14 citations). Feng Yu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Ji Li, Weihong Ge, Huaijun Zhu, Yubing Zhu, Kaixian Chen, Dongxiang Liu, Xu Shen, Hualiang Jiang, Junrong Zhu and Du‐Jiang Xie. Their work appears in journals such as International Journal of Molecular Sciences, Acta Pharmacologica Sinica, Medicine, Evidence-based Complementary and Alternative Medicine and Frontiers in Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.